HealthEquity, Inc.

HQY Healthcare Health Information Services

HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

92.03 0.48 −0.52%
Market cap
$7.7B
P/E
33.0×
Fwd P/E
30.2×
Dividend yield
—
F-score
9/9
Altman Z
4.39
Beneish M
−2.77
Dividend safety
n/a
Jan '17 Jan '18 Jan '19 Jan '20 Jan '21 Jan '22 Jan '23 Jan '24 Jan '25 Jan '26
Piotroski F-Score
8 6 7 3 5 4 7 8 6 9
P/E ratio
102.78 64.90 52.39 98.60 710.59 0.00 0.00 116.28 99.48 34.97
P/S ratio
15.20 13.30 13.42 8.32 8.49 5.87 5.96 6.47 8.00 5.71
Altman Z-Score
96.66 82.26 72.62 2.22 3.33 2.50 3.04 4.13 5.02 4.39
Altman Z″-Score (non-manufacturers)
21.69 21.98 22.03 1.55 2.05 2.10 2.38 3.27 2.79 3.26
P/FCF ratio
82.36 63.18 39.18 70.35 73.53 1,135.06 163.00 32.87 0.00 18.37
P/Operating CF
186.17 154.02 118.11 143.11 102.21 87.87 92.60 83.91 126.63 63.60
Beneish M-Score
(2.70) (2.65) (2.80) (2.73) (2.60) (2.50) (2.66) (2.72) (2.73) (2.77)
P/B ratio
10.35 8.82 8.08 4.30 4.51 2.40 2.71 3.18 4.54 3.56
Price to Tangible BV
14.10 11.83 9.81 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
14.19 12.25 12.16 10.26 9.38 6.80 6.74 6.96 8.64 6.21
EV/EBITDA
46.52 39.96 36.42 40.40 44.40 43.85 33.48 25.42 31.73 17.06
EV/Operating CF
55.51 34.42 30.80 51.96 37.90 36.51 38.56 28.64 30.51 17.84
EV/FCF
76.88 58.20 35.51 86.70 81.30 1,315.29 184.29 35.35 (62.62) 19.97
Quick Ratio
12.57 12.78 13.33 1.73 1.96 2.04 2.68 4.35 2.65 2.82
Current Ratio
12.79 12.95 13.58 1.96 2.25 2.29 2.92 4.76 3.06 3.27
Net Debt/EBITDA
(3.32) (3.41) (3.77) 7.62 4.24 6.01 3.87 1.72 2.33 1.34
Debt/Assets
0.00% 0.00% 0.00% 47.59% 36.40% 29.96% 29.96% 27.66% 30.63% 28.32%
Debt/Equity
0.00 0.00 0.00 1.18 0.72 0.50 0.49 0.43 0.50 0.45
Asset Turnover
0.72 0.71 0.65 0.35 0.28 0.26 0.28 0.32 0.36 0.38
Operating CF/Net income
1.73 1.73 1.53 2.65 20.56 (3.18) (5.76) 4.36 3.51 2.12
Capex/Depreciation
(0.96) (2.09) (0.82) (0.72) (0.80) (0.97) (0.72) (0.30) (3.07) (0.31)
Interest Coverage
— 198.61 287.67 3.11 0.98 (0.66) 0.19 2.12 2.68 5.64
ROE
11.33% 15.57% 17.95% 5.26% 0.73% (2.74%) (1.39%) 2.83% 4.66% 10.19%
ROA
10.57% 14.61% 16.81% 2.58% 0.33% (1.52%) (0.84%) 1.78% 2.92% 6.30%
ROIC
31.57% 32.08% 41.99% 2.34% 1.04% (0.59%) 0.22% 2.94% 3.53% 7.34%
Return on Tangible Assets
13.86% 18.74% 19.77% 22.18% 3.10% (19.99%) (9.88%) 12.48% 29.79% 60.01%
Average Days of Receivables
34.79 34.35 32.62 48.62 36.21 42.18 41.02 38.30 35.90 34.37
Research and Development Expense of Revenue
12.54% 11.93% 12.20% 14.58% 17.01% 20.80% 22.44% 21.89% 19.96% 19.99%
Selling, General and Administrative Expense of Revenue
21.57% 21.02% 21.77% 19.65% 18.33% 19.04% 19.30% 18.30% 18.59% 16.38%
Intangible Assets out of Total Assets
0.25 0.24 0.17 0.82 0.77 0.84 0.84 0.79 0.83 0.81
Share Based Compensation of Revenue
4.71% 6.23% 7.33% 7.49% 5.84% 6.97% 7.27% 7.72% 8.04% 5.56%
Graham Net Nets
0.07 0.08 0.09 (0.28) (0.14) (0.20) (0.16) (0.09) (0.09) (0.10)
Graham Number
6.73 10.04 14.37 15.22 7.02 0.00 0.00 18.65 24.66 37.02
Earnings Yield
0.97% 1.54% 1.91% 1.01% 0.14% (0.99%) (0.51%) 0.86% 1.01% 2.86%
Free Cash Flow Yield
1.21% 1.58% 2.55% 1.42% 1.36% 0.09% 0.61% 3.04% (1.73%) 5.44%
Revenue per Share
3.04 3.81 4.65 7.94 9.88 9.10 10.21 11.68 13.81 15.25
Operating CF per Share
0.78 1.35 1.83 1.57 2.45 1.70 1.78 2.84 3.91 5.31
Capex per Share
(0.22) (0.55) (0.24) (0.63) (1.31) (1.65) (1.41) (0.54) (5.82) (0.57)
Free Cash Flow per Share
0.56 0.80 1.59 0.94 1.14 0.05 0.37 2.30 (1.91) 4.74
Cash per Share
3.08 3.98 5.85 2.86 4.43 2.71 3.01 4.72 3.41 3.70
Shareholders Equity per Share
4.47 5.74 7.72 15.37 18.57 22.28 22.45 23.78 24.35 24.46
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
4.47 5.74 7.72 15.37 18.57 22.28 22.45 23.78 24.35 24.46
Free Cash Flow
32.92 48.32 98.38 62.94 84.66 3.91 31.52 196.75 (165.60) 408.32
Working Capital
185.12 244.91 365.62 145.36 255.48 198.15 251.83 440.35 321.43 355.43
Capital Expenditures
(12.67) (33.38) (15.04) (42.07) (96.96) (137.08) (119.13) (46.07) (505.45) (48.78)
Net Current Asset Value
183.62 242.51 361.74 (1,237.39) (871.50) (903.19) (810.37) (571.33) (855.89) (760.85)
EV/EBIT
61.40 51.68 44.98 70.86 202.34 0.00 641.42 59.10 63.88 25.29
Capex to Sales
0.07 0.15 0.05 0.08 0.13 0.18 0.14 0.05 0.42 0.04
Price to Operating Income
65.78 56.10 49.63 57.50 183.00 0.00 567.33 54.94 59.09 23.26
Other line items
Depreciation/Fixed assets
2.55 2.04 2.22 1.73 4.16 6.06 12.79 25.93 50.79 49.01
Cash ROIC
7.44% 8.24% 11.73% 2.58% 3.14% 0.13% 1.03% 5.94% (4.78%) 12.07%
Accounts Receivable Turnover
11.39 11.89 12.15 11.02 10.21 9.45 9.35 9.91 10.77 10.87
Accounts Payable Turnover
25.48 33.54 35.71 54.96 113.78 22.76 17.85 29.06 32.01 30.19
Inventory Turnover
118.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
16.33 9.34 12.12 7.05 1.85 30.30 13.72 11.66 12.41 11.09
Days of Inventory on Hand
3.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
15.65 19.30 23.64 48.27 71.82 80.10 92.13 100.86 111.45 120.85
Average Payables
2.83 2.82 2.97 3.75 2.80 14.58 20.72 12.97 13.20 13.26
Average Inventory
0.61 — — — — — — — — —
Average Assets
249.47 324.15 439.59 1,537.50 2,637.69 2,908.75 3,098.00 3,126.35 3,306.17 3,414.44
Average Common Equity
232.70 304.11 411.68 753.69 1,204.51 1,615.65 1,874.11 1,965.33 2,074.97 2,111.05

Fold the line items

Columns are period end dates